Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Centric, Randomized, Double-Blind, Parallel, Phase-III Study to Assess Efficacy of PMZ-2010 as a Resuscitative Agent for Hypovolemic Shock to be Used as an Adjuvant to Standard Shock Treatment

NCT04045327 is registered in ClinicalTrials.gov with Pharmazz, Inc. as lead sponsor.

NCT NCT04045327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04045327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Centric, Randomized, Double-Blind, Parallel, Phase-III Study to Assess Efficacy of PMZ-2010 as a Resuscitative Agent for Hypovolemic Shock to be Used as an Adjuvant to Standard Shock Treatment
Lead sponsor
Pharmazz, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2019
Completion date
September 27, 2019
Enrollment
105 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hypovolemic shock